(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.85%) $83.14
(-1.16%) $1.619
(-0.43%) $2 337.10
(0.95%) $27.51
(0.63%) $927.90
(-0.20%) $0.933
(-0.11%) $11.01
(-0.25%) $0.798
(0.00%) $92.17
-1.45% $ 2.04
Live Chart Being Loaded With Signals
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States...
Stats | |
---|---|
Volumen de hoy | 6 759.00 |
Volumen promedio | 15 388.00 |
Capitalización de mercado | 7.45M |
EPS | $-0.570 ( 2024-04-04 ) |
Próxima fecha de ganancias | ( $-1.040 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.530 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-26 | Siegert Michelle | Buy | 9 900 | Stock Option (Right to Buy) |
2023-01-26 | Wasilewski Margaret | Buy | 11 400 | Stock Option (Right to Buy) |
2023-01-26 | Raad Teofilo David | Buy | 34 900 | Stock Option (Right to Buy) |
2023-01-26 | Bazemore Todd | Buy | 1 700 | Stock Option (Right to Buy) |
2023-01-26 | Higgins Michael J | Buy | 2 436 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 13 676 591 | Sell: 104 308 |
Pulmatrix Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pulmatrix Inc Finanzas
Annual | 2023 |
Ingresos: | $7.30M |
Beneficio Bruto: | $5.82M (79.79 %) |
EPS: | $-3.87 |
FY | 2023 |
Ingresos: | $7.30M |
Beneficio Bruto: | $5.82M (79.79 %) |
EPS: | $-3.87 |
FY | 2022 |
Ingresos: | $6.07M |
Beneficio Bruto: | $4.53M (74.55 %) |
EPS: | $-5.43 |
FY | 2021 |
Ingresos: | $5 169.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.00745 |
Financial Reports:
No articles found.
Pulmatrix Inc
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma, and in patients with cystic fibrosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with stable moderate-severe chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico